Twitter LinkedIn
    Wednesday, May 25
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Investments»Oxford Endovascular raises USD10m in a Series A funding round
    Investments

    Oxford Endovascular raises USD10m in a Series A funding round

    April 8, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Oxford Endovascular, a British MedTech company and spin-out from Oxford University developing a treatment for brain aneurysms that will overcome challenges with existing medical devices, has raised USD10 million in a series A funding round

    The funding which was conducted in Pounds Sterling includes a GBP3 million investment from new investors Vulpes Investment Management, who joined to lead the round and funds from the Additio Investment Group. Existing investors Oxford Sciences Innovation PLC, Parkwalk Advisors, Perivoli Innovations, Oxford Investment Consultants, the University of Oxford and private individuals also followed on. The raise will enable the company to complete development work and gain first in-human data through an early feasibility clinical study. This will then set the scene for a further fundraise for larger FDA and CE Mark clinical trials paving the way for entry into various international markets valued at over USD1 billion. The China market for the company’s innovative technology is developing strongly and also presents strong opportunities.

    The raise follows on from previous non-dilutive grant funding won, including EUR3 million from the European Union’s prestigious Horizon 2020 SME Instrument and GBP350,000 from Innovate UK, the UK’s innovation agency Smart Grant program. During the Covid-19 crisis in 2020 the company was also one of only seven start-ups across Europe & Israel that won funding in return for options, to the tune of EUR500,000.

    Read more

    Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals and transactions Fundraising Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Cathay Capital launches new €500m health fund

    May 24, 2022

    Moove acquires PetroChoice from Golden Gate Capital in £479m deal

    May 24, 2022

    Investcorp to invest $400 mn Indian schooling infra

    May 24, 2022

    AfricInvest closes largest African midcap-focused fund at over $400m

    May 24, 2022

    Comments are closed.

    Other Articles

    Carlyle to exit clinic chain Ameos as founder, ICG take full control

    February 23, 2021

    Odore raises USD830k to transform beauty marketing

    April 24, 2021

    Nuclein Raises $14M in Series B Funding

    April 3, 2021

    BV Investment Partners invests in PixelMEDIA

    January 20, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?